MGRM - Monogram Orthopedics Inc. Company Cash on Hand

Monogram Technologies is burning through reserves due to R&D expenses, as evidenced by the change in cash balance. The current level of 0.01 reflects the latest metric value. Its leadership status in personalized robotics allows Monogram Technologies (MGRM) to maintain pricing power. Meanwhile, a strategic alliance with clinics is introducing innovations in endoprosthetics, stimulating future M&A activity.
Summary analytical data breakdowns for Monogram Technologies Inc. (MGRM)

Monogram Technologies develops high-tech AI systems for orthopedics, protected by a substantial patent portfolio. Current liquid assets directly determine the business's ability to fund the development of custom prosthetics without external borrowing. This metric aggregates balances across all accounts, measuring the absolute volume of cash available to cover operating expenses. By analyzing the amount of operating cash, an investor assesses the balance between financial security and capital efficiency.